Price T Rowe Associates Inc Adc Therapeutics Sa Transaction History

Price T Rowe Associates Inc

$869 Billion
Q3 2024

A detailed history of Price T Rowe Associates Inc transactions in Adc Therapeutics Sa stock. As of the latest transaction made, Price T Rowe Associates Inc holds 28,831 shares of ADCT stock, worth $57,373. This represents 0.0% of its overall portfolio holdings.

Number of Shares

28,831

Previous 22,476 28.27%

Holding current value

$57,373

Previous $0 Infinity%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$2.59 - $4.01 $16,459 - $25,483	6,355 Added 28.27%	28,831 $91,000
Q2 2024 Aug 14, 2024	BUY	$2.55 - $5.09 $57,313 - $114,402	22,476 New	22,476 $0
Q2 2023 Aug 14, 2023	SELL	$1.9 - $2.66 $160,740 - $225,036	-84,600 Reduced 6.48%	1,221,838 $2.63 Million
Q1 2023 May 15, 2023	SELL	$1.92 - $5.45 $347,264 - $985,725	-180,867 Reduced 12.16%	1,306,438 $2.55 Million
Q4 2022 Feb 14, 2023	BUY	$2.87 - $5.24 $851,101 - $1.55 Million	296,551 Added 24.9%	1,487,305 $5.71 Million
Q3 2022 Nov 14, 2022	SELL	$4.66 - $10.31 $3.59 Million - $7.94 Million	-770,456 Reduced 39.28%	1,190,754 $5.74 Million
Q2 2022 Aug 15, 2022	SELL	$5.96 - $14.99 $2.99 Million - $7.52 Million	-501,426 Reduced 20.36%	1,961,210 $15.6 Million
Q1 2022 May 16, 2022	SELL	$13.28 - $20.03 $5.16 Million - $7.79 Million	-388,801 Reduced 13.64%	2,462,636 $36.2 Million
Q4 2021 Feb 14, 2022	BUY	$19.29 - $31.51 $437,825 - $715,182	22,697 Added 0.8%	2,851,437 $57.6 Million
Q3 2021 Nov 15, 2021	BUY	$20.45 - $30.0 $3.4 Million - $4.98 Million	166,155 Added 6.24%	2,828,740 $76.8 Million
Q2 2021 Aug 16, 2021	SELL	$20.38 - $27.04 $1.7 Million - $2.25 Million	-83,209 Reduced 3.03%	2,662,585 $64.8 Million
Q1 2021 May 17, 2021	BUY	$22.75 - $34.05 $17.7 Million - $26.6 Million	780,033 Added 39.68%	2,745,794 $67 Million
Q4 2020 Feb 16, 2021	BUY	$25.26 - $38.02 $49.7 Million - $74.7 Million	1,965,761 New	1,965,761 $62.9 Million

Others Institutions Holding ADCT

# of Institutions

Shares Held

55M

Call Options Held

82.7K

Put Options Held

31.5K

View Full List

About ADC Therapeutics SA

Ticker ADCT
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,645,296
Market Cap $155M
Description
ADC Therapeutics SA, a commercial-stage biotechnology company, develops antibody drug conjugates (ADC) for patients suffering from hematological malignancies and solid tumors. Its flagship product ZYNLONTA that is in Phase II clinical trial for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma;...

More about ADCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Adc Therapeutics Sa Transaction History